The introduction of α-synuclein into mouse models of Alzheimer's disease, either by intracerebral injection or transgenic overexpression, is found to inhibit the formation of hippocampal amyloid-β plaques.
- Teresa Bachhuber
- Natalie Katzmarski
- Melanie Meyer-Luehmann